Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04059939 · ClinicalTrials.gov registry record · NA
Evidence-Based Interventions to Enhance Outcomes Among Struggling Readers
A NA study, sponsored by Boston University Charles River Campus.
- Completed
- Registry status
- NA
- Development phase
- 542
- Enrollment target
NCT04059939 is a NA study that has completed, run by Boston University Charles River Campus. The registered enrollment target is 542 participants.
The verdict
NCT04059939, a NA study, has completed, sponsored by Boston University Charles River Campus.
- COMPLETED
- Registry status
- NA
- Development phase
- 542 participants
- Enrollment target
Study Summary
Despite decades of research on reading disabilities, little is known about improving reading in the middle grades (i.e., grades 3-6) and advancements have been hindered by the narrow focus on reading problems alone without acknowledgement of non-academic factors shown to affect learning (e.g., child self-regulation). This proposal employs a highly innovative approach aimed at improving intervention outcomes through the integration of evidence-based practices for addressing reading, as well as self-regulation/socioemotional skills, difficulties known to occur in a substantial percentage of struggling readers and to negatively influence academic performance. This project represents translational research that directly informs the practice community (schools, clinicians, teachers, parents), by identifying novel instructional practices that can be aggregated to more effectively influence student outcomes and reduce disparities in academic and socioemotional domains.
Interventions
- OTHER Reading
- BEHAVIORAL Anxiety Management
- OTHER Classroom Business as Usual
- OTHER Attention Control (math practice)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 542 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2024-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04059939
The ClinicalTrials.gov registry entry for NCT04059939 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 542 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University Charles River Campus, which has 104 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Reading is the first listed.
NCT04059939 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04059939 about?
NCT04059939 is a clinical study titled "Evidence-Based Interventions to Enhance Outcomes Among Struggling Readers". Despite decades of research on reading disabilities, little is known about improving reading in the middle grades (i.e., grades 3-6) and advancements have been hindered by the narrow focus on reading problems alone without acknowledgement of non-academic factors shown to affect learning (e.g., child...
What is the current status of trial NCT04059939?
This trial is currently completed. It is a NA study. The enrollment target is 542 participants. The study started on 2017-08-01. Estimated completion is 2024-07-31.
What interventions are being tested in trial NCT04059939?
The interventions under investigation include: Reading (OTHER), Anxiety Management (BEHAVIORAL), Classroom Business as Usual (OTHER), Attention Control (math practice) (OTHER).
Who is sponsoring clinical trial NCT04059939?
This trial is sponsored by Boston University Charles River Campus, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.